Baxter Infusion Pump Recall Requirements Issued By FDA
The FDA has laid out requirements for the recall of Colleague Volumetric Infusion pumps by Baxter Healthcare Corp., instructing the company on how to refund or provide replacements for about 200,000 potentially dangerous infusion pumps. The FDA announced the infusion pump recall requirements, a little more than two months after it announced that Baxter would be forced to take its Colleague pump off of the market. Problems with Baxter Colleague infusion pumps have been linked to more than 500 deaths and 56,000 reports of adverse events.
Read the full story here.
-
FDA Makes Class I Recall for Infusion Pumps
Shipment of Alaris infusion pumps resumed
Vascular Insights receives FDA nod for infusion catheter
NuOrtho Gets Approval For Ceruleau
ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device
